243
Views
1
CrossRef citations to date
0
Altmetric
Research Articles

Toward Consent in Molecular HIV Surveillance?: Perspectives of Critical Stakeholders

ORCID Icon, ORCID Icon & ORCID Icon

References

  • AIDS United, & US People Living with HIV Caucus. 2018. Meaningful involvement of people with HIV/AIDS (MIPA): ‘Nothing About Us Without Us’. http://aidsunitedbtc.wpengine.com/wp-content/uploads/2021/05/Meaningful_Involvement_of_People_with_HIV_AIDS_MIPA.pdf
  • Artavia, D. 2019. Watch activists storm the stage at USCA, protesting neglect from CDC. HIV Plus Magazine, September 5. https://www.hivplusmag.com/treatment/2019/9/05/activists-storm-stage-hiv-conference-citing-neglect-cdc
  • Bayer, R. 2010. Mass testing and mass treatment for epidemic HIV: The ethics of medical research is no guide. Public Health Ethics 3 (3):301–2. doi:10.1093/phe/phq022.
  • Bayer, R., and A. L. Fairchild. 2004. The genesis of public health ethics. Bioethics 18 (6):473–92. doi:10.1111/j.1467-8519.2004.00412.x.
  • Bell, S. A., V. Delpech, D. Raben, J. Casabona, N. Tsereteli, and J. de Wit. 2016. HIV pre-test information, discussion or counselling? A review of guidance relevant to the WHO European Region. International Journal of STD & AIDS 27 (2):97–104. doi:10.1177/0956462415584468.
  • Benjamin, R. 2016. Informed refusal: Toward a justice-based bioethics. Science, Technology, & Human Values 41 (6):967–90. doi:10.1177/0162243916656059.
  • Bernard, E. J., A. McClelland, B. Cardell, C. Chung, M. Castro-Bojorquez, M. French, D. Hursey, N. Khanna, M. B. Minalga, A. Spieldenner, et al. 2020. We are people, not clusters! The American Journal of Bioethics: AJOB 20 (10):1–4. doi:10.1080/15265161.2020.1809550.
  • Bollinger, J. M., G. Geller, E. May, J. Brewer, L. M. Henry, and J. Sugarman. 2023. Challenges in obtaining the informed perspectives of stakeholders regarding HIV molecular epidemiology. Journal of Acquired Immune Deficiency Syndromes 93 (2):87–91. doi:10.1097/QAI.0000000000003179.
  • Branson, B. M., H. H. Handsfield, M. A. Lampe, R. S. Janssen, A. W. Taylor, S. B. Lyss, and J. E. Clark, Centers for Disease Control and Prevention (CDC). 2006. Revised recommendations for HIV testing of adults, adolescents, and pregnant women in health-care settings. MMWR. Recommendations and Reports : Morbidity and Mortality Weekly Report. Recommendations and Reports 55 (RR-14):1–17. quiz CE1-4.
  • Braun, V., and V. Clarke. 2019. Reflecting on reflexive thematic analysis. Qualitative Research in Sport, Exercise and Health 11 (4):589–97. doi:10.1080/2159676X.2019.1628806.
  • Braunack-Mayer, A. J. 2001. What makes a problem an ethical problem? An empirical perspective on the nature of ethical problems in general practice. Journal of Medical Ethics 27 (2):98–103. doi:10.1136/jme.27.2.98.
  • Buchbinder, M., E. Juengst, S. Rennie, C. Blue, and D. L. Rosen. 2022. Advancing a data justice framework for public health surveillance. AJOB Empirical Bioethics 13 (3):205–13. doi:10.1080/23294515.2022.2063997.
  • Budin-Ljøsne, I., H. J. A. Teare, J. Kaye, S. Beck, H. B. Bentzen, L. Caenazzo, C. Collett, F. D’Abramo, H. Felzmann, T. Finlay, et al. 2017. Dynamic consent: A potential solution to some of the challenges of modern biomedical research. BMC Medical Ethics 18 (1), 4. doi:10.1186/s12910-016-0162-9.
  • Centers for Disease Control and Prevention (CDC). 2018. Detecting and responding to HIV transmission clusters: A guide for health departments. Centers for Disease Control and Prevention (CDC). https://www.cdc.gov/hiv/pdf/funding/announcements/ps18-1802/CDC-HIV-PS18-1802-AttachmentE-Detecting-Investigating-and-Responding-to-HIV-Transmission-Clusters.pdf
  • Chung, C., N. Khanna, B. Cardell, A. Spieldenner, S. Strub, A. McClelland, M. French, M. Gagnon, and A. Guta. 2019. Consent and criminalisation concerns over phylogenetic analysis of surveillance data. The Lancet HIV 6 (7):e420. doi:10.1016/S2352-3018(19)30138-9.
  • Costanza-Chock, S. 2020. Design justice: Community-led practices to build the worlds we need. Cambridge, MA: The MIT Press.
  • Dawson, L., and S. R. Latham. 2020. Molecular HIV surveillance and public health ethics: Old wine in new bottles. The American Journal of Bioethics: AJOB 20 (10):39–41. doi:10.1080/15265161.2020.1806393.
  • Dennis, A., S. Day, S. Rennie, and K. Sullivan. 2023. Revitalizing community engagement in the public health use of molecular HIV epidemiology. University of North Carolina, Chapel Hill. https://dennis.unc.edu/wp-content/uploads/sites/3288/2023/04/MHE_WhitePaper_2023-04-28.pdf
  • Epstein, S. 1995. The construction of lay expertise: AIDS activism and the forging of credibility in the reform of clinical trials. Science, Technology & Human Values 20 (4):408–37. http://www.jstor.org.proxy.lib.umich.edu/stable/689868. doi:10.1177/016224399502000402.
  • Evans, D., and N. D. Benbow. 2018. Ethical considerations for a public health response using molecular HIV surveillance data. Project Inform and Northwestern University. https://www.projectinform.org/surveillance2017/
  • Fairchild, A. L., and R. Bayer. 2011. HIV surveillance, public health, and clinical medicine—will the walls come tumbling down? The New England Journal of Medicine 365 (8):685–7. doi:10.1056/NEJMp1107294.
  • Fauci, A. S., R. R. Redfield, G. Sigounas, M. D. Weahkee, and B. P. Giroir. 2019. Ending the HIV epidemic: A plan for the United States. JAMA 321 (9):844–5. doi:10.1001/jama.2019.1343.
  • Gräf, T., and J. T. Herbeck. 2019. Genetic clusters and transmission in transgender women. The Lancet HIV 6 (3):e143–e144. doi:10.1016/S2352-3018(18)30365-5.
  • Guta, A., J. Voronka, and M. Gagnon. 2018. Resisting the digital medicine panopticon: Toward a bioethics of the oppressed. The American Journal of Bioethics: AJOB 18 (9):62–4. doi:10.1080/15265161.2018.1498936.
  • Hastings, C., A. McClelland, A. Guta, M. Owino, E. Manning, M. Orsini, R. Elliott, M. Gagnon, and S. Molldrem. 2021. Intersections of treatment, surveillance, and criminal law responses to HIV and COVID-19. American Journal of Public Health 111 (7):1252–4. doi:10.2105/AJPH.2021.306236.
  • Hedgecoe, A. 2010. Bioethics and the reinforcement of socio-technical expectations. Social Studies of Science 40 (2):163–86. doi:10.1177/0306312709349781.
  • Hedgecoe, A. M. 2004. Critical bioethics: Beyond the social science critique of applied ethics. Bioethics 18 (2):120–43. doi:10.1111/j.1467-8519.2004.00385.x.
  • Herwehe, J., W. Wilbright, A. Abrams, S. Bergson, J. Foxhood, M. Kaiser, L. Smith, K. Xiao, A. Zapata, and M. Magnus. 2012. Implementation of an innovative, integrated electronic medical record (EMR) and public health information exchange for HIV/AIDS. Journal of the American Medical Informatics Association : JAMIA 19 (3):448–52. doi:10.1136/amiajnl-2011-000412.
  • HIV Justice Network. 2021. Molecular HIV Surveillance “a perfect storm” in the context of HIV-related criminalisation. https://www.hivjustice.net/news/press-release-molecular-hiv-surveillance-a-perfect-storm-in-the-context-of-hiv-related-criminalisation/
  • Kaiser Family Foundation. 2021. HIV viral suppression rate in U.S. lowest among comparable high-income countries. https://www.kff.org/hivaids/slide/hiv-viral-suppression-rate-in-u-s-lowest-among-comparable-high-income-countries/
  • Kaye, D. K., G. Chongwe, and N. K. Sewankambo. 2019. Ethical tensions in the informed consent process for randomized clinical trials in emergency obstetric and newborn care in low and middle-income countries. BMC Medical Ethics 20 (1):27. doi:10.1186/s12910-019-0363-0.
  • Kaye, J., E. A. Whitley, D. Lund, M. Morrison, H. Teare, and K. Melham. 2015. Dynamic consent: A patient interface for twenty-first century research networks. European Journal of Human Genetics : EJHG 23 (2):141–6. doi:10.1038/ejhg.2014.71.
  • Klugman, C. M. 2020. What is a bioethics of the oppressed in the age of COVID-19? The American Journal of Bioethics : AJOB 20 (10):29–31. doi:10.1080/15265161.2020.1806397.
  • Knight, R., J. Shoveller, D. Greyson, T. Kerr, M. Gilbert, and K. Shannon. 2014. Advancing population and public health ethics regarding HIV testing: A scoping review. Critical Public Health 24 (3):283–95. doi:10.1080/09581596.2013.800188.
  • Lee, L. M. 2020. An ethics for public health surveillance. The American Journal of Bioethics : AJOB 20 (10):61–3. doi:10.1080/15265161.2020.1806382.
  • Lee, L. M., C. M. Heilig, and A. White. 2012. Ethical justification for conducting public health surveillance without patient consent. American Journal of Public Health 102 (1):38–44. doi:10.2105/AJPH.2011.300297.
  • Llibre, J. M., J. M. Schapiro, and B. Clotet. 2010. Clinical implications of genotypic resistance to the newer antiretroviral drugs in HIV‐1–infected patients with virological failure. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America 50 (6):872–81. doi:10.1086/650732.
  • McClelland, A., A. Guta, and M. Gagnon. 2020. The rise of molecular HIV surveillance: Implications on consent and criminalization. Critical Public Health 30 (4):487–93. doi:10.1080/09581596.2019.1582755.
  • McCray, E., and J. Mermin. 2017. ‘Dear Colleague’ letter announcing CDC’s position that ‘people who take ART daily as prescribed and achieve and maintain an undetectable viral load have effectively no risk of sexually transmitting the virus to an HIV-negative partner.’ [Dear Colleague Letter]. https://web.archive.org/web/20171102063511/https://www.cdc.gov/hiv/library/dcl/dcl/092717.html
  • Mithani, Z., J. Cooper, and J. W. Boyd. 2021. Race, power, and COVID-19: A call for advocacy within bioethics. The American Journal of Bioethics : AJOB 21 (2):11–8. doi:10.1080/15265161.2020.1851810.
  • Molldrem, S. 2020. How to build an HIV out of care watch list: Remaking HIV surveillance in the era of treatment as prevention. First Monday 20 (10):1–31. doi:10.5210/fm.v25i10.10295.
  • Molldrem, S., and A. K. J. Smith. 2020a. Reassessing the ethics of molecular HIV surveillance in the era of cluster detection and response: Toward HIV data justice. The American Journal of Bioethics : AJOB 20 (10):10–23. doi:10.1080/15265161.2020.1806373.
  • Molldrem, S., and A. K. J. Smith. 2020b. Technology changes the ethical stakes in HIV surveillance and prevention: Response to open peer commentaries on “Reassessing the Ethics of Molecular HIV surveillance in the era of cluster detection and response. The American Journal of Bioethics : AJOB 20 (10):W1–W3. doi:10.1080/15265161.2020.1815472.
  • Molldrem, S., A. K. J. Smith, and A. McClelland. 2023a. Advancing dialogue about consent and molecular HIV surveillance in the United States: Four proposals following a federal advisory panel’s call for major reforms. The Milbank Quarterly. Online ahead of print. doi:10.1111/1468-0009.12663.
  • Molldrem, S., A. K. J. Smith, and A. McClelland. 2023b. Predictive analytics in HIV surveillance require new approaches to data ethics, rights, and regulation in public health. Critical Public Health 33 (3):275–81. doi:10.1080/09581596.2022.2113035.
  • Mutenherwa, F., D. R. Wassenaar, and T. de Oliveira. 2019a. Ethical issues associated with HIV molecular epidemiology: A qualitative exploratory study using inductive analytic approaches. BMC Medical Ethics 20 (1), 67. doi:10.1186/s12910-019-0403-9.
  • Mutenherwa, F., D. R. Wassenaar, and T. de Oliveira. 2019b. Experts’ perspectives on key ethical issues associated with HIV phylogenetics as applied in HIV transmission dynamics research. Journal of Empirical Research on Human Research Ethics: JERHRE 14 (1):61–77. doi:10.1177/1556264618809608.
  • Mykhalovskiy, E., K. L. Frohlich, B. Poland, E. Di Ruggiero, M. J. Rock, and L. Comer. 2019. Critical social science with public health: Agonism, critique and engagement. Critical Public Health 29 (5):522–33. doi:10.1080/09581596.2018.1474174.
  • Nelson, B. 2020. Questioning the benefits of molecular surveillance. POZ Magazine, June 29. https://www.poz.com/article/questioning-benefits-molecular-surveillance
  • Oster, A., M. France, A. M, and Mermin, J. 2018. Molecular epidemiology and the transformation of HIV prevention. JAMA 319 (16):1657–8. doi:10.1001/jama.2018.1513.
  • Oster, A. M., S. B. Lyss, R. P. McClung, M. Watson, N. Panneer, A. L. Hernandez, K. Buchacz, S. E. Robilotto, K. G. Curran, R. Hassan, et al. 2021. HIV cluster and outbreak detection and response: The science and experience. American Journal of Preventive Medicine 61 (5 Suppl 1):S130–S142. doi:10.1016/j.amepre.2021.05.029.
  • People with AIDS Advisory Committee. 1983. The denver principles. http://www.actupny.org/documents/denver_principles.pdf
  • Presidential Advisory Council on HIV/AIDS (PACHA). 2022. Molecular HIV surveillance and cluster detection and response resolution. https://files.hiv.gov/s3fs-public/2022-11/PACHA-resolution-on-Molecular-HIV-Surveillance-Cluster-Detection-and-Response-10-17-22.pdf
  • Rowe, R. 2021. Social determinants of health in the Big Data mode of population health risk calculation. Big Data & Society 8 (2):205395172110628. doi:10.1177/20539517211062881.
  • Rudolph, A. E., O. Martinez, R. Davison, and C. B. Amuchi, Department of Epidemiology and Biostatistics, Temple University College of Public Health, Philadelphia, USA. 2020. Informed consent for HIV phylogenetic research: A case study of urban individuals living with HIV approached for enrollment in an HIV study. Ehquidad Revista Internacional de Políticas de Bienestar y Trabajo Social 2020 (14):129–44. doi:10.15257/ehquidad.2020.0015.
  • Sandset, T. 2020. The ethical and epistemological pitfalls of translating phylogenetic HIV testing: From patient-centered care to surveillance. Humanities and Social Sciences Communications 7 (1) doi:10.1057/s41599-020-0522-4.
  • Scanlon, T. 2000. What we owe to each other. The Belknap press of Harvard University Press.
  • Schairer, C. E., S. R. Mehta, S. A. Vinterbo, M. Hoenigl, M. Kalichman, and S. J. Little. 2019. Trust and expectations of researchers and public health departments for the use of HIV Molecular epidemiology. AJOB Empirical Bioethics 10 (3):201–13. doi:10.1080/23294515.2019.1601648.
  • Schairer, C., S. R. Mehta, S. A. Vinterbo, M. Hoenigl, M. Kalichman, and S. Little. 2017. Perceptions of molecular epidemiology studies of HIV among stakeholders. Journal of Public Health Research 6 (3):992. doi:10.4081/jphr.2017.992.
  • Seear, K., and E. Lenton. 2021. Becoming posthuman: Hepatitis C, the race to elimination and the politics of remaking the subject. Health Sociology Review : The Journal of the Health Section of the Australian Sociological Association 30 (3):229–43. doi:10.1080/14461242.2021.1971102.
  • Sharp, J., C. D. Angert, T. Mcconnell, P. Wortley, E. Pennisi, L. Roland, C. C. Mehta, W. S. Armstrong, B. Shah, and J. A. Colasanti. 2019. Health information exchange: A Novel re-linkage intervention in an urban health system. Open Forum Infectious Diseases 6 (10):ofz402. doi:10.1093/ofid/ofz402.
  • Shook, A. G., S. E. Buskin, M. Golden, J. C. Dombrowski, J. Herbeck, R. J. Lechtenberg, and R. Kerani. 2022. Community and provider perspectives on molecular HIV surveillance and cluster detection and response for HIV prevention: Qualitative findings from king County, Washington. The Journal of the Association of Nurses in AIDS Care: JANAC 33 (3):270–82. doi:10.1097/JNC.0000000000000308.
  • Smith, A. K. J., M. D. M. Davis, J. MacGibbon, T. R. Broady, J. Ellard, J. Rule, T. Cook, E. Duck-Chong, M. Holt, and C. E. Newman. 2023. Engaging stigmatised communities in Australia with digital health systems: Towards data justice in public health. Sexuality Research & Social Policy : journal of NSRC : SR & SP 20 (3):1–12. doi:10.1007/s13178-023-00791-6.
  • Smith, J. C. 2020. Fourth Pillar or “Third Rail?:” towards a community-centered understanding of the role of molecular HIV surveillance in ending the HIV epidemic in the United States. The American Journal of Bioethics : AJOB 20 (10):5–6. doi:10.1080/15265161.2020.1812266.
  • Spieldenner, A., M. French, V. Ray, B. Minalga, C. Sardina, R. Suttle, M. Castro-Bojorquez, O. Lewis, and L. Sprague. 2022. The meaningful involvement of people with HIV/AIDS (MIPA): The participatory praxis approach to community engagement on HIV surveillance. Journal of Community Engagement and Scholarship 14 (2):1–11. https://digitalcommons.northgeorgia.edu/cgi/viewcontent.cgi?article=1359&context=jces. doi:10.54656/jces.v14i2.26.
  • Subrahmanyam, V. 2021. A public health reset through contractualism. Voices in Bioethics 7 doi:10.52214/vib.v7i.8600.
  • Sun, N., K. Esom, M. Dhaliwal, and J. J. Amon. 2020. Human Rights and digital health technologies. Health and Human Rights 22 (2):21–32.
  • Sweeney, P., L. I. Gardner, K. Buchacz, P. M. Garland, M. J. Mugavero, J. T. Bosshart, R. L. Shouse, and J. Bertolli. 2013. Shifting the paradigm: Using HIV surveillance data as a foundation for improving HIV care and preventing HIV infection. The Milbank Quarterly 91 (3):558–603. doi:10.1111/milq.12018.
  • The Lancet HIV. (2022). Levelling up HIV testing for the endgame. The Lancet HIV, 9(5), e299. doi:10.1016/S2352-3018(22)00106-0.
  • Williams, H., K. Spencer, C. Sanders, D. Lund, E. A. Whitley, J. Kaye, and W. G. Dixon. 2015. Dynamic consent: A possible solution to improve patient confidence and trust in how electronic patient records are used in medical research. JMIR Medical Informatics 3 (1):e3. doi:10.2196/medinform.3525.
  • World Health Organization. 2020. Consolidated Guidelines on HIV Testing Services, 2019 p. Geneva. https://www.who.int/publications/i/item/978-92-4-155058-1

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.